Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

DNA - Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Close
6.69
-0.400   -5.979%

Share volume: 1,444,209
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST

PREVIOUS CLOSE
CHG
CHG%
$7.09
-0.40
-5.64%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-17.91%
1 Month
-54.23%
3 Months
-70.10%
6 Months
-89.00%
1 Year
-92.57%
2 Year
-93.57%
Key data
Stock price
$6.69
P/E Ratio 
-12.85
DAY RANGE
$6.64 - $7.26
EPS 
-$0.45
52 WEEK RANGE
$6.64 - $90.40
52 WEEK CHANGE
-$0.93
MARKET CAP 
11.534 B
YIELD 
N/A
SHARES OUTSTANDING 
1.724 B
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,764,703
AVERAGE 30 VOLUME 
$1,550,214
Company detail
CEO:
Region: US
Website: ginkgobioworks.com
Employees: 1,261
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.

Recent news